Skip to main content
Atrás
ADDLF logo

AddLife AB (publ)

Calidad de datos: 100%
Sobrecompra
ADDLF
OTC Healthcare Medical - Instruments & Supplies
$42.00
$0.00 (0.00%)
Cap. Mercado: 4.93B
Rango del Día
$7.94 $42.00
Rango de 52 Semanas
$7.94 $42.00
Volumen
3,000
Promedio 50D / 200D
$42.00 / $42.00
Cierre Anterior
$42.00

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E 8.8 0.2
P/B 0.9 3.0
ROE % 10.4 3.6
Net Margin % 5.4 3.8
Rev Growth 5Y % 6.9 9.9
D/E 0.0 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $0.94
$0.94 – $0.94
11.93B 1
FY2027 $0.84
$0.84 – $0.84
11.47B 1
FY2026 $0.78
$0.78 – $0.78
10.78B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-04 $0.19 $0.23 +20.5%
2025-10-23 $0.13 $0.14 +5.4%
2025-07-15 $0.18 $0.09 -52.0%
2025-04-25 $0.16 $0.10 -40.0%
2025-02-05 $0.12 $0.07 -43.9%
2024-10-23 $0.11 $0.02 -82.8%
2024-07-12 $0.13 $0.06 -55.9%
2024-05-08 $0.13 $0.05 -64.2%

Dividend History

6 yr streak

Yield

0.00%

Payout Ratio

0.16%

Growth (3Y)

-24.49%

Growth (5Y)

-19.67%

Ex-Date Payment Date Amount Yield
May 12, 2025 May 15, 2025 $0.08 0.19%
May 10, 2024 May 16, 2024 $0.05 0.12%
May 06, 2022 May 12, 2022 $0.20 0.50%
May 06, 2021 May 12, 2021 $0.18 0.91%
Nov 20, 2020 Nov 26, 2020 $0.06 0.30%
May 10, 2019 May 16, 2019 $0.23 0.92%
Jun 01, 2018 Jun 08, 2018 $0.25 1.19%
May 30, 2017 Jun 05, 2017 $0.17 0.82%

Puntos Clave

Revenue grew 6.91% annually over 5 years — modest growth
Earnings grew 122.22% over the past year
ROE of 10.42% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 1.39B in free cash flow
P/E of 8.80 — trading at a low valuation

Crecimiento

Revenue Growth (5Y)
6.91%
Revenue (1Y)1.52%
Earnings (1Y)122.22%
FCF Growth (3Y)73.02%

Calidad

Return on Equity
10.42%
ROIC13.68%
Net Margin5.36%
Op. Margin9.51%

Seguridad

Debt / Equity
0.00
Current Ratio1.04
Interest Coverage0.00

Valoración

P/E Ratio
8.80
Forward P/E53.92
P/B Ratio0.91
EV/EBITDA4.14
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.52% Revenue Growth (3Y) 3.83%
Earnings Growth (1Y) 122.22% Earnings Growth (3Y) 71.68%
Revenue Growth (5Y) 6.91% Earnings Growth (5Y) -6.06%
Profitability
Revenue (TTM) 10.44B Net Income (TTM) 560.00M
ROE 10.42% ROA 4.41%
Gross Margin 38.09% Operating Margin 9.51%
Net Margin 5.36% Free Cash Flow (TTM) 1.39B
ROIC 13.68% FCF Growth (3Y) 73.02%
Safety
Debt / Equity 0.00 Current Ratio 1.04
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.16%
Dividend Growth (3Y) -24.49% Dividend Growth (5Y) -19.67%
Consecutive Div Years 6 yrs
Valuation
P/E Ratio 8.80 Forward P/E 53.92
P/B Ratio 0.91 P/S Ratio 0.47
PEG Ratio 0.69 Forward PEG N/A
EV/EBITDA 4.14 Fwd EV/EBITDA 2.58
Forward P/S 0.46 Fwd Earnings Yield 1.85%
FCF Yield 28.26%
Market Cap 4.93B Enterprise Value 4.11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 10.44B 10.29B 9.69B 9.08B 7.99B
Net Income 560.00M 252.00M 190.00M 480.00M 719.00M
EPS (Diluted) 4.59 2.07 1.56 3.95 6.01
Gross Profit 3.98B 3.86B 3.60B 3.43B 2.86B
Operating Income 993.00M 721.00M 585.00M 808.00M 996.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.71B 13.06B 12.75B 13.06B 10.60B
Total Liabilities 7.26B 7.75B 7.79B 8.09B 6.30B
Shareholders' Equity 5.44B 5.31B 4.96B 4.97B 4.29B
Total Debt 0.0 5.07B 5.29B 5.59B 4.10B
Cash & Equivalents 813.00M 331.00M 272.00M 376.00M 345.30M
Current Assets 4.15B 3.93B 3.61B 3.57B 2.75B
Current Liabilities 3.99B 3.19B 4.31B 4.46B 4.91B

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#764 of 826
15

Actividad Reciente

Salió Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entró Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró Defensive Investing (Benjamin Graham)
Mar 24, 2026